ELLANSÉ™ S

Ellanse S is a high-performance dermal filler manufactured by AQTIS Medical BV, a privately- held company headquartered in the Netherlands. Formulated with polycaprolactone microspheres (which are suspended in an aqueous carboxymethyl cellulose gel carrier), Ellanse S is indicated for the treatment of aging signs (such as facial wrinkles) as well as other facial age-related conditions. Plus, it provides correction by volumization through bio-stimulation.

Excellent safety profile: The active ingredients of Ellanse S are FDA-approved and CE-marked. They have a long history of safe use in medical industry.
Superior performance: Ellanse S offers clear advantages over NASHA-based dermal fillers in terms of efficiency.

2 prefilled 1ml syringes
4 sterile 27G3/4″ needles
Package insert

Ellanse S works by promoting the formation of collagen (around the microspheres) and triggering the body’s natural response to foreign bodies. This helps to increase soft tissue and contouring.

Polycaprolactone (PCL) microspheres
Carboxymethyl cellulose (CMC) gel-carrier

The treatment results of Ellanse S typically last between a year to four years. Keep in mind that individual results may vary depending on a range of factors such as age and skin type.

Ellanse S requires minimal recovery time. The skin reactions associated with Ellanse S will usually disappear in a week.

The use of prescription and non-prescription drugs may affect the treatment outcomes of Ellanse S. Prior to treatment, carefully assess the medication history of patients.
Ellanse S is not intended for self-administration. It should be injected by a trained medical professional who has been adequately trained.

Swelling
Redness
Bruising